C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A01K 67/027 (2006.01) A61K 39/395 (2006.01) A61P 27/06 (2006.01) C07K 14/47 (2006.01) C12N 9/00 (2006.01) C12N 9/12 (2006.01) C12N 15/00 (2006.01) C12Q 1/48 (2006.01) G01N 33/50 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2401775
This invention provides methods and compositions for diagnosing and treating glaucoma based on determining the level of a Frizzle Related Protein (FRP), a component of the wingless (Wnt) signaling pathway. The method can include the detection of a genetic lesion like polymorphic allele (e.g. FRP promoter, ...) for diagnosing glaucoma. This invention also discloses the use of transgenic animals for the study of glaucoma (screening for therapeutics, animal disease model, ...).
La présente invention concerne des procédés et compositions convenant au diagnostic et au traitement du glaucome.
Clark Abbot F.
Fingert John
Mcnatt Loretta
Stone Edwin M.
Wang Wan-Heng
Alcon Inc.
Novartis Ag
Riches Mckenzie & Herbert Llp
University Of Iowa Research Foundation
LandOfFree
Diagnostics and therapeutics for glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostics and therapeutics for glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostics and therapeutics for glaucoma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1997887